Volkan Adsay Selected Research

Volkan Adsay Research Topics

Disease

41	Neoplasms (Cancer) 07/2022 - 01/2001
16	Carcinoma (Carcinomatosis) 01/2022 - 01/2001
15	Adenocarcinoma 01/2022 - 10/2003
13	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2003
6	Neoplasms, Cystic, Mucinous, and Serous 03/2021 - 01/2001
6	Neoplasm Metastasis (Metastasis) 07/2019 - 01/2009
4	Cysts 01/2022 - 12/2011
3	Adenoma (Adenomas) 01/2022 - 07/2004
3	Carcinogenesis 01/2022 - 05/2003
3	Polyps 03/2021 - 01/2020
3	Fibrosis (Cirrhosis) 08/2012 - 08/2003
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 08/2015
2	Metaplasia 01/2021 - 01/2020
2	Hyperplasia 01/2021 - 09/2017
2	Pancreatitis 01/2021 - 09/2017
2	Pancreatic Cyst 11/2019 - 01/2019
2	Neuroendocrine Carcinoma 11/2019 - 03/2010
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 07/2019
2	Acinar Cell Carcinoma 07/2019 - 09/2016
2	Ischemia 10/2017 - 03/2007
2	Serous Cystadenoma 11/2014 - 12/2011
2	Breast Neoplasms (Breast Cancer) 05/2007 - 08/2003
1	Choledochal Cyst (Choledochal Cysts) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Gallstones (Gallstone) 01/2022
1	Carcinoma in Situ 07/2021
1	Microsatellite Instability 01/2021
1	Inflammation (Inflammations) 01/2021
1	Cholangitis 01/2021
1	Autolysis 01/2021
1	Medullary Carcinoma 11/2020
1	Paraganglioma (Paragangliomas) 09/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Cholangiocarcinoma 11/2019
1	Pathologic Constriction (Stenosis) 11/2019
1	Jaundice (Icterus) 11/2019
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Rheumatic Nodule 07/2019
1	Erythema Nodosum 07/2019
1	Necrolytic Migratory Erythema 07/2019
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 07/2019
1	Hypertension (High Blood Pressure) 10/2017
1	Choledocholithiasis 10/2017
1	Arteriosclerosis 10/2017
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2017

Drug/Important Bio-Agent (IBA)

8	MucinsIBA 01/2022 - 08/2003
8	EnzymesIBA 01/2022 - 12/2005
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2003
4	Biological ProductsIBA 01/2019 - 12/2011
3	CholesterolIBA 03/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 11/2019 - 01/2001
3	Mucin-1 (CA 15-3 Antigen)IBA 07/2017 - 07/2004
3	Cisplatin (Platino)FDA LinkGeneric 09/2016 - 12/2003
2	CateninsIBA 07/2022 - 12/2012
2	phytobacteriomycin (PBM)IBA 01/2022 - 09/2017
2	Bile Pigments (Bilin)IBA 07/2021 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2016
2	LipidsIBA 09/2020 - 03/2008
2	VimentinIBA 01/2020 - 06/2012
2	Keratins (Keratin)IBA 01/2020 - 01/2016
2	Fetal Proteins (Fetoprotein)IBA 11/2019 - 08/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 01/2019
2	ChromatinIBA 11/2019 - 01/2017
2	TrypsinIBA 07/2019 - 12/2012
2	Lipase (Acid Lipase)FDA Link 07/2019 - 12/2012
2	Phosphotransferases (Kinase)IBA 12/2017 - 10/2003
2	CAM 5.2 antigenIBA 07/2017 - 03/2017
2	Glycoproteins (Glycoprotein)IBA 03/2017 - 09/2004
2	Monoclonal AntibodiesIBA 10/2016 - 01/2009
2	Phenobarbital (Luminal)FDA Link 10/2016 - 11/2012
2	Gemcitabine FDA Link 09/2016 - 12/2005
2	ParaffinIBA 08/2016 - 01/2016
2	GadoliniumIBA 08/2012 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 03/2008
2	ErbB Receptors (EGF Receptor)IBA 05/2007 - 05/2003
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 03/2021
1	Histone-Lysine N-MethyltransferaseIBA 01/2021
1	Fixatives (Pickling Agents)IBA 01/2021
1	LigandsIBA 11/2020
1	PlatinumIBA 06/2020
1	Cadherins (E-Cadherin)IBA 05/2020
1	BilirubinIBA 11/2019
1	bis(diazo)benzidine (BDB)IBA 11/2019
1	Chymotrypsin FDA Link 07/2019
1	Glucagon (Glukagon)FDA Link 07/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017
1	Amyloid (Amyloid Fibrils)IBA 09/2017

Therapy/Procedure

7	Therapeutics 03/2021 - 12/2005
7	Drug Therapy (Chemotherapy) 06/2020 - 08/2003
6	Cholecystectomy 01/2020 - 08/2011
4	Pancreaticoduodenectomy 10/2021 - 11/2012
3	Neoadjuvant Therapy 01/2022 - 01/2021
3	Radiotherapy 03/2010 - 12/2003
2	Pancreatectomy 01/2022 - 03/2012
2	Chemoradiotherapy 08/2015 - 12/2003
1	Precision Medicine 01/2022
1	Immunotherapy 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 09/2017